Stockreport

Tempus Announces Four Abstracts Accepted For Presentation at the European Society for Medical Oncology Congress 2024

Tempus AI, Inc. - Class A  (TEM) 
PDF CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announ [Read more]